Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Natera Inc (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8025
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Partnerships 15
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Equity Offering 18
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc – Key Competitors 22
Natera Inc – Key Employees 23
Natera Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jan 04, 2017: Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening 25
Financial Announcements 26
Aug 08, 2018: Natera reports second quarter 2018 financial results 26
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 28
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 30
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 32
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 36
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 38
Corporate Communications 40
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 40
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 41
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 42
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Natera Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc, Key Competitors 22
Natera Inc, Key Employees 23
Natera Inc, Subsidiaries 24

List of Figures
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Shimizu Corporation:企業の戦略・SWOT・財務分析
    Shimizu Corporation - Strategy, SWOT and Corporate Finance Report Summary Shimizu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Asahi Kasei Corporation:企業のM&A・事業提携・投資動向
    Asahi Kasei Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asahi Kasei Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Rose Petroleum plc (ROSE):企業の財務・戦略的SWOT分析
    Summary Rose Petroleum Plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • Adris grupa d.d.:企業の戦略・SWOT・財務情報
    Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report Summary Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • DaChan Food (Asia) Limited:企業の戦略・SWOT・財務情報
    DaChan Food (Asia) Limited - Strategy, SWOT and Corporate Finance Report Summary DaChan Food (Asia) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Woodside Petroleum Limited:企業の戦略・SWOT・財務分析
    Woodside Petroleum Limited - Strategy, SWOT and Corporate Finance Report Summary Woodside Petroleum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Teva Pharmaceuticals USA Inc:企業のM&A・事業提携・投資動向
    Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Manhattan Associates Inc (MANH):企業の財務・戦略的SWOT分析
    Manhattan Associates Inc (MANH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Italgas SpA-石油・ガス分野:企業M&A・提携分析
    Summary Italgas SpA (Italgas), a subsidiary of Snam SpA, is an oilfield service company that offers transportation and dispatching of natural gas, liquefied natural gas regasification, and storage and distribution of natural gas. The company's activities include rhino-analytical tests; instrumental …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Gulf Pharmaceutical Industries PSC (JULPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primar …
  • PsiOxus Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transf …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆